Recent Developments in Structure-Based Virtual Screening Approaches
Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year. To solve these problems, new and innovate technologies are needed that make the drug discovery process of small-molecules more time and cost-efficient, and which allow to target previously undruggable target classes such as protein-protein interactions. Structure-based virtual screenings have become a leading contender in this context. In this review, we give an introduction to the foundations of structure-based virtual screenings, and survey their progress in the past few years. We outline key principles, recent success stories, new methods, available software, and promising future research directions. Virtual screenings have an enormous potential for the development of new small-molecule drugs, and are already starting to transform early-stage drug discovery.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoverySimilar Papers 제목 키워드 기반
QuickBind: A Light-Weight And Interpretable Molecular Docking Model
Predicting a ligand's bound pose to a target protein is a key component of early-stage computational drug discovery. Recent developments in machine learning methods have focused on improving pose quality at the cost of m…
Drug DiscoveryMolecular DockingPose PredictionScaling Structure Aware Virtual Screening to Billions of Molecules with SPRINT
Virtual screening of small molecules against protein targets can accelerate drug discovery and development by predicting drug-target interactions (DTIs). However, structure-based methods like molecular docking are too sl…
Drug DiscoveryMolecular DockingEfficient Budget Allocation for Large-Scale LLM-Enabled Virtual Screening
Screening tasks that aim to identify a small subset of top alternatives from a large pool are common in business decision-making processes. These tasks often require substantial human effort to evaluate each alternative'…
Computational EfficiencyPharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling
As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid sc…
Drug DiscoveryGraph MatchingInstance SegmentationPose Prediction+1Protein language models are performant in structure-free virtual screening
Hitherto virtual screening has been typically performed using a structure-based drug design paradigm. Such methods typically require the use of molecular docking on high-resolution three-dimensional structures of a targe…
Drug DesignMolecular Docking